Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension

Saved in:
Bibliographic Details
Published in:Molecular genetics and metabolism 2012-02, Vol.105 (2), p.S25-S26
Main Authors: Crombez, Eric, Kishnani, Priya, Turkia, Hadhami Ben, Gonzalez, Derlis, Zimran, Ari, Kabra, Madhulika, Lukina, Elena, Giraldo, Pilar, Kisinovsky, Isaac, Bavdekar, Ashish, Dridi, Marie-Françoise Ben, Gupta, Neerja
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2011.11.044